New publication where Attana technology has been applied for lead candidate selection of a new antibody-based anti-viral treatment of Hepatitis B infection

Share this post

We use cookies to improve the functionality, performance, and effectiveness of our website. Detailed information on the use of cookies is provided in our Privacy Policy and Terms of Use. By continuing to use this site, or by clicking “I agree” you consent to the use of cookies.